Divis Laboratories Ltd | DIVI - Ebitda

Cena Akcji
6,681.00
Dzienna Zmiana
30.00 0.45%
Miesięcznie
14.21%
Rocznie
8.67%
Q2 Prognozy TE
6,358.14




Ebitda Zmiana Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Aurobindo Pharma INR 17.73B 952.4M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Lupin INR 23.09B 318.5M 2025-12
Moderna USD -790M 582M 2025-12
Organon & Co USD 415M 32M 2026-03
Revvity USD 272.91M 24M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Tilray USD 8.36M 1.82M 2025-09
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12